Harrow Health Inc.

NASDAQ: HROW · Real-Time Price · USD
38.68
-1.33 (-3.32%)
At close: Aug 15, 2025, 12:18 PM

Harrow Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-17.48M -24.41M -14.09M -18.01M
Depreciation & Amortization
14.54M 12.34M 3.67M 2.4M
Stock-Based Compensation
17.62M 15.7M 7.97M 5.75M
Other Working Capital
42,569B -4.26M -3.22M 103K
Other Non-Cash Items
7.75M 7.35M 9.72M 677K
Deferred Income Tax
n/a n/a n/a 14.52M
Change in Working Capital
-44.63M -7.13M -5.57M -253K
Operating Cash Flow
-22.2M 3.84M 1.71M 5.08M
Capital Expenditures
-38.67M -152.55M -7.77M -28.51M
Cash Acquisitions
n/a n/a 30K 9.83M
Purchase of Investments
n/a n/a n/a 16.9M
Sales Maturities Of Investments
5,510B n/a n/a 9.83M
Other Investing Acitivies
-5,510B -151.09M 6M -26.73M
Investing Cash Flow
-33.16M -152.55M -1.74M -18.69M
Debt Repayment
29.78M 74.64M 31.72M 71.07M
Common Stock Repurchased
n/a n/a n/a -11M
Dividend Paid
n/a n/a n/a -127K
Other Financial Acitivies
-2.36M -12.63M -234K -19.12M
Financial Cash Flow
28.53M 126.53M 54.14M 51.47M
Net Cash Flow
-26.84M -22.18M 54.1M 37.87M
Free Cash Flow
-60.88M -148.71M -6.07M -23.43M